Puma Biotech (PBYI) Inks Agreement for Takeda's Alisertib - September 21, 2022 - Zacks.com
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock | Nasdaq
StockTwits June 2017 Power Rankings: 10 Stocks You Have To Watch | by Stocktwits, Inc. | The Stocktwits Blog
Puma Biotechnology (PBYI) Stock Price, News & Analysis
StockTwits June 2017 Power Rankings: 10 Stocks You Have To Watch | by Stocktwits, Inc. | The Stocktwits Blog
PCLI Completes Acquisition of JR Development LLC | PCLI Stock News
Puma Biotech (PBYI) Q3 Earnings Top, Nerlynx Sales View Up - November 4, 2022 - Zacks.com
Finance Sites Turn To StockTwits For Curated Stock Tweets | TechCrunch
Washington Prime Group Announces Compliance with NYSE Continued Listing Standards | WPG Stock News
Puma Cancer Drug Suffers 'Approvability Risk' On Extreme Side Effect | Stock News & Stock Market Analysis - IBD
Puma Biotechnology Crashed After Lagging More Bullish Views For Breast Cancer Drug Nerlynx | Stock News & Stock Market Analysis - IBD
Solar Power World Names Ameresco a Top Solar Contractor of 2022 | AMRC Stock News
This Biotech Stock Has Soared 84% This Week On Breast-Cancer Drug News | Investor's Business Daily
Puma Biotechnologys Impressive Q3 2023 Financial Results - Best Stocks
Supernus, Puma Among 5 Big Biotech Stock Winners, Losers Monday | Stock News & Stock Market Analysis - IBD
Cosmos Group Holdings Inc Subsidiary to Mint The World's First Coinllectibles Watch Fusion NFT with Graphic Artist Bosslogic and Swiss Luxury Watch Brand Quinting | COSG.OB Stock News
Puma Biotechnology (PBYI) Stock Price, News & Analysis
Puma Races To Eight-Month High On Breast Cancer Drug Success | Stock News & Stock Market Analysis - IBD
Gena Wang | Barclays Stock Analyst - TipRanks.com
Stocktwits on X: "Puma Biotechnology is tanking after-hours, down over -30% on the likelihood it won't get approval from European agency for its cancer drug. https://t.co/To0cg7EEgW $PBYI https://t.co/QMKqfhSV7l" / X
Puma Biotechnology (NASDAQ:PBYI) Stock Rating Upgraded by StockNews.com - MarketBeat
Blog Advertising Service Skyscraper Raises $500K Seed Round Led By Howard Lindzon And Tom Peterson Of Social Leverage | TechCrunch
Puma Biotech's (PBYI) Nerlynx Aids Top Line, Overdependence a Woe - August 26, 2022 - Zacks.com
NI Announces New LabVIEW Features to Turn Test Performance into Business Performance | NATI Stock News
